- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01365273
Open, Prosp, Rand. Invest. Evaluating Pain With Mepitel One vs.Bridal Veil and Staples on Split Thickness Skin Grafts
Open, Prospective, Randomised Investigation Evaluating Pain With the Use of Mepitel One vs.Bridal Veil and Staples on Split Thickness Skin Grafts
This investigation is an open, randomised investigation. Approximately 40 subjects in 4-5 centres in the US with deep-partial of full thickness burns in need of skin grafts will be enrolled.The subjects will be equally randomised to either treatment with Mepitel One or bridal veil together with staples.
The primary objective is to compare pain at the time of dressing change for the use of Mepitel One versus bridal veil together with staples on deep partial or full thickness burns requiring skin grafts.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Skin grafts are placed over excised areas of full thickness injuries and usually attached with sutures or staples. While useful in anchoring the graft in place, subjects often complain of pain from the staples as wound healing progresses.Pulling and sticking are common complaints.There is also a possibility that staples become embedded in the graft which leads to disruption of otherwise healed area, increased pain and anxiety for the subject as well as anxiety for the staff.
Graft take can be optimized with appropriate medical management. Use of non-adherent dressings to protect the graft is customary. Various types of netting-style are used, such as Bridal veil, a sterile product which is fixed over the graft with staples.
Silicone net dressings have also been used successfully to prevent lifting and adherence of skin grafts to the dressings, prevent pain and promote healing. Mepitel One is a sterile, transparent, and flexible wound contact layer consisting of perforated polyurethane film coated with Safetac soft silicone adhesive on one side. Mepitel One is available in various sizes and can be left in place for several days depending on the wound/skin condition.
Evaluation of burns will be performed at Baseline. Skin graft assessment will be performed at Day 7 and Day 14. End of study will be considered the time that graft is considered to have >95% take.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
Florida
-
Tampa, Florida, United States, 33606
- University Foundation for Education & Research, Inc
-
-
Georgia
-
Augusta, Georgia, United States, 30909
- Joseph M. Still Research Foundation, Inc.
-
-
Kansas
-
Kansas City, Kansas, United States, 66160
- 5028 Delp Bldg, Mail stop 1011
-
-
Pennsylvania
-
Upland, Pennsylvania, United States, 19013
- Natham Speare Regional Burn Treatment Ctr., Crozer Chester Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Inclusion Criteria
- Subjects presenting with 1% - 25% Total Body Surface Area (TBSA) deep partial or full-thickness burns requiring skin graft
- At least 1%-10% TBSA is available for grafting that can be considered for study site selection (must have intact, healthy peri-wound area around entire portion of this burned site)
- Both genders with age ≥18 years but < 70 years
- Signed informed consent
Exclusion Criteria:
- Subjects with chronic wounds
- Subjects who are on mechanical ventilation
- Subjects with dermatologic skin conditions or necrotizing disorders
- Diagnosed underlying disease(s) (HIV/AIDS, cancer and severe anaemia)judged by the investigator to be a potential interference in the treatment
- Subjects treated with systemic glucocorticosteroids, except subjects taking occasional doses or doses less than 10 mg prednisolon/day or equivalent
- Use of immunosuppressive agents, radiation or chemotherapy within the past 30 days
- Known allergy/hypersensitivity to any of the components of the investigational products
- Subjects with physical and/or mental conditions that are not expected to comply with the investigation
- Participation in other clinical investigation(s) within 1 month prior to start of the investigation
- Previously randomised to this investigation
- Pregnancy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Bridal Veil together with staples
Standard of care.
Bridal Veil is fixed over the graft with staples.
|
|
Active Comparator: Mepitel One
Device, dressing
|
Dressing
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
VAS Score for Pain Before Dressing Removal
Time Frame: At visit 6, day 7
|
Pain was measured with Visual Analogue Scale (VAS)(100 mm) measuring from 0 = "no pain" at one end to 100 = "most intense pain imagaginable" at the other end.
|
At visit 6, day 7
|
VAS Score for Pain During Dressing Removal
Time Frame: Visit 6, day 7
|
Pain when half of the study product(s) has been removed measued with Visual Analogue Scale (VAS).0
= "no pain" till 100 = "worst pain".
|
Visit 6, day 7
|
VAS Score for Pain After Dressing Removal
Time Frame: Visit 6, day 7
|
Pain after the dressing removal measued with Visual Analogue Scale (VAS).0
= "no pain" till 100 = "worst pain".
|
Visit 6, day 7
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Mary Lou Patton, MD, Nathan Speare Regional Burn Treatment Ctr. Croer Chester Medical Center
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MPTO 04
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Deep Partial Thickness Burn
-
Amarantus BioScience Holdings, Inc.Amarex Clinical ResearchUnknownThermal Injury | Deep Partial-Thickness Burn | Full-Thickness BurnUnited States
-
Chulalongkorn UniversityNational Science and Technology Development Agency, ThailandCompletedDeep Partial Thickness BurnThailand
-
GeneScience Pharmaceuticals Co., Ltd.Third Military Medical University; Shanghai Jiao Tong University School of... and other collaboratorsCompletedDeep Partial Thickness Burn
-
Stratatech, a Mallinckrodt CompanyCompletedDeep Partial-thickness BurnUnited States
-
Nanomedic Technologies Ltd.CompletedPartial Thickness BurnIsrael
-
Molnlycke Health Care ABRecruitingPartial-thickness BurnUnited States
-
University of TennesseeMedline IndustriesCompletedBurns | Partial-thickness BurnUnited States
-
KeraNetics, LLCUnited States Department of Defense; Wake Forest UniversityRecruitingPartial-thickness BurnUnited States
-
King Edward Medical UniversityUnknownPartial-thickness BurnPakistan
-
J. Peter Rubin, MDUnited States Department of Defense; Synedgen, Inc.Terminated
Clinical Trials on Mepitel One
-
Molnlycke Health Care ABWithdrawnAcute WoundsGermany
-
Molnlycke Health Care ABCompleted
-
University of BirminghamWellcome Trust; University Hospital BirminghamCompleted
-
Mayo ClinicCompletedBreast CancerUnited States
-
Sunnybrook Health Sciences CentreCompletedBreast Cancer | Radiation DermatitisCanada
-
Sunnybrook Health Sciences CentreActive, not recruitingBreast Cancer | Radiation DermatitisCanada
-
Odense University HospitalHerning Hospital; Vejle HospitalCompletedBreast Neoplasms | Radiodermatitis | Side Effect
-
Allegheny Singer Research Institute (also known...TerminatedBreast Cancer | Radiotherapy Side Effect | Radiation Dermatitis | Radiotherapy; Complications | Radiotherapy; Adverse Effect, Dermatitis or Eczema | Radiation BurnUnited States
-
Jules Bordet InstituteNot yet recruitingRadiation Toxicity | Radiodermatitis | Radiotherapy Side Effect
-
Molnlycke Health Care ABCompletedA Clinical Investigation to Evaluate Efficacy of Mepitel Ag in Partial Thickness Second Degree BurnsBurns | Wound HealingUnited States